Abstract
Metabolism A plethora of studies have uncovered correlations between gut microbiome composition and common disorders such as metabolic disease. The hope is that these correlations can be translated into therapies using mechanism-based approaches. An alternative approach is fecal microbiota transplantation (FMT), a procedure in which gut microbiota from healthy donors are delivered to individuals who have, or are at risk of developing, a specific disorder. Yu et al. conducted a small, double-blind clinical trial to determine whether obese adults at risk of developing type 2 diabetes would benefit from oral FMT capsules derived from healthy, lean donors. After 3 months, they found durable microbial shifts in the recipients but no clinically meaningful changes in their metabolism or weight. PLOS Med. 17 , e1003051 (2020).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
